德国植物药在我国的发展情况及我国中药国际化发展的思考  

The Development of German Botanical Medicine in China and the Thinking About the International Development of Chinese Medicine

作　　者：格日勒 元文君 付微 李丽萍 周静 Ge Rile;Yuan Wenjun;Fu Wei;Li Liping;Zhou Jing(Jiangzhong Pharmaceutical Co.,Ltd.,Nanchang 330004,China)

机构地区：[1]江中药业股份有限公司

出　　处：《亚太传统医药》2024年第4期1-5,共5页Asia-Pacific Traditional Medicine

摘　　要：我国是中药的发源地,使用历史悠久,“一带一路”倡议加快中药走出国门,但当前我国中药在国际市场发展有限,如何促进我国中药在国际主流医药市场的发展,这是当前国内中药行业面对的主要问题。德国是欧洲植物药大国,其在科研、生产、销售方面均处于全球领先水平。因此,系统分析德国植物药的发展历程,及其在我国的发展情况,如注册申报、销售等,并结合我国中药发展现状,提出推动我国中药国际化发展的对策,以期为我国中药发展提供参考,助力中药国际化发展。China is the birthplace of traditional Chinese medicine,the use of a long history,“One Belt and One Road”initiative accelerates Chinese medicine to go abroad,but the current Chinese traditional medicine in the international market development is limited,how to promote the development of Chinese traditional medicine in the mainstream pharmaceutical market,which is the main problem facing the current domestic Chinese traditional medicine industry.Germany is a big country of European plant medicine,which is at the global leading level in scientific research,production and sales.Therefore,this study systematically analyzed the development process of German plant medicine and its development in China,including registration,application,and sales,and combined with the development status of Chinese traditional medicine,proposed several countermeasures to promote the international development of Chinese traditional medicine.In order to provide a reference for the development of Chinese traditional medicine and help the international development of Chinese traditional medicine.

关 键 词：植物药 注册申报 专利保护 中药发展 

分 类 号：R288[医药卫生—中药学]